An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
Clinical trial NCT00478660 · COMPLETED
Trial details
- NCT number
- NCT00478660
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Enrollment
- 1250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.